Matches in Wikidata for { <http://www.wikidata.org/entity/Q96616921> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q96616921 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96616921 description "scientific article published on 01 June 2020" @default.
- Q96616921 description "wetenschappelijk artikel" @default.
- Q96616921 description "наукова стаття, опублікована 1 червня 2020" @default.
- Q96616921 name "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 name "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 type Item @default.
- Q96616921 label "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 label "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 prefLabel "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 prefLabel "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 P1433 Q96616921-16D1514A-8F9F-4DCF-B5CB-6F1B9086E8CB @default.
- Q96616921 P1476 Q96616921-3EFE4A64-EFE2-4A9D-B085-833CF2DAA948 @default.
- Q96616921 P2093 Q96616921-13035DFC-4B6B-4D5F-A45D-75A8D75D0DB0 @default.
- Q96616921 P2093 Q96616921-1E81F907-8DBD-4E62-9B03-57918497A117 @default.
- Q96616921 P2093 Q96616921-46C8CE1E-331E-4B78-AC3C-065EDCFE6D2D @default.
- Q96616921 P2093 Q96616921-577E0DF3-0A48-4C74-9D08-6C786BE0E1D4 @default.
- Q96616921 P2093 Q96616921-6BB7896B-3C99-45FC-BABC-6253B06FCD35 @default.
- Q96616921 P2093 Q96616921-7C7D5A09-544C-4DBB-AD09-5E7F4EEFE024 @default.
- Q96616921 P2093 Q96616921-A1503341-985D-46BA-9C04-6F60B7DE91DA @default.
- Q96616921 P2093 Q96616921-C43919A5-2D66-48FF-8E02-8C583B5037A4 @default.
- Q96616921 P304 Q96616921-BF3324DE-9F28-4BA9-AF01-F93150E688E2 @default.
- Q96616921 P31 Q96616921-A48AD883-DA1D-4FB9-878F-3526A265465B @default.
- Q96616921 P356 Q96616921-45806E0B-88CB-451A-9673-EA26F8C98FC6 @default.
- Q96616921 P433 Q96616921-F9AE63E8-EC76-4A27-8659-7353DCCC6C6E @default.
- Q96616921 P478 Q96616921-484010D2-68D1-4D38-8AAD-2189BA63B5F2 @default.
- Q96616921 P577 Q96616921-E2C81FA0-C376-4BD9-8FB3-2E7332078EE0 @default.
- Q96616921 P698 Q96616921-F793539A-1618-481B-B4B0-C38E04D08223 @default.
- Q96616921 P921 Q96616921-C5D89CA5-05DE-4A10-B445-3302FF03A066 @default.
- Q96616921 P932 Q96616921-7BBFC56D-F164-4614-9063-0F4B308C95C0 @default.
- Q96616921 P356 MD.0000000000020809 @default.
- Q96616921 P698 32569228 @default.
- Q96616921 P1433 Q15716652 @default.
- Q96616921 P1476 "Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report" @default.
- Q96616921 P2093 "Cuiju Tang" @default.
- Q96616921 P2093 "Dongying Gu" @default.
- Q96616921 P2093 "Jiali Dai" @default.
- Q96616921 P2093 "Jinfei Chen" @default.
- Q96616921 P2093 "Jingsun Wei" @default.
- Q96616921 P2093 "Xiaowei Wei" @default.
- Q96616921 P2093 "Yang Gong" @default.
- Q96616921 P2093 "Yuetong Chen" @default.
- Q96616921 P304 "e20809" @default.
- Q96616921 P31 Q13442814 @default.
- Q96616921 P356 "10.1097/MD.0000000000020809" @default.
- Q96616921 P433 "25" @default.
- Q96616921 P478 "99" @default.
- Q96616921 P577 "2020-06-01T00:00:00Z" @default.
- Q96616921 P698 "32569228" @default.
- Q96616921 P921 Q12859063 @default.
- Q96616921 P932 "7310977" @default.